a2 Milk dual listed on the ASX at the end of 2015 and we've had a very positive ride since that time. There's a lot of interest in dairy and in our view, interest in our particular business and our business model, which is very different in our opinion to any other dairy company.
We are the only company that's involved in the production, marketing and sale of a2 beta-casein protein based products. It's fair to say that the growth of the company in recent years has been on the back of success in the Australian market and our corporate office is now based here in North Sydney.
We have a market cap of around NZ$1.3 billion now and we've been doing a number of profit upgrades during the year, we've had three during this year, and our current outlook for FY16 is for revenue in the order of NZ$335 million.
